Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Strategies for viral removal and inactivation.

Burstyn DG, Hageman TC.

Dev Biol Stand. 1996;88:73-9. Review.

PMID:
9119165
2.

Contamination of genetically engineered Chinese hamster ovary cells.

Burstyn DG.

Dev Biol Stand. 1996;88:199-203.

PMID:
9119137
3.

A pertussis outbreak in a Wisconsin nursing home.

Addiss DG, Davis JP, Meade BD, Burstyn DG, Meissner M, Zastrow JA, Berg JL, Drinka P, Phillips R.

J Infect Dis. 1991 Oct;164(4):704-10.

PMID:
1894932
4.

Monoclonal antibodies to pertussis toxin: utilization as probes of toxin function.

Kenimer JG, Kim KJ, Probst PG, Manclark CR, Burstyn DG, Cowell JL.

Hybridoma. 1989 Feb;8(1):37-51.

PMID:
2466764
5.

Sensitivity and specificity of clinical case definitions for pertussis.

Patriarca PA, Biellik RJ, Sanden G, Burstyn DG, Mitchell PD, Silverman PR, Davis JP, Manclark CR.

Am J Public Health. 1988 Jul;78(7):833-6.

6.

Evidence for a high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled.

Steketee RW, Wassilak SG, Adkins WN Jr, Burstyn DG, Manclark CR, Berg J, Hopfensperger D, Schell WL, Davis JP.

J Infect Dis. 1988 Mar;157(3):434-40.

PMID:
3257783
7.

A comparison of laboratory and clinical methods for diagnosing pertussis in an outbreak in a facility for the developmentally disabled.

Steketee RW, Burstyn DG, Wassilak SG, Adkins WN Jr, Polyak MB, Davis JP, Manclark CR.

J Infect Dis. 1988 Mar;157(3):441-9.

PMID:
2893828
8.

Outbreaks of pertussis in the United States: the Wisconsin experience.

Partiarca PA, Steketee RW, Biellik RJ, Wassilak SG, Brink EW, Burstyn DG, Manclark CR, Davis JP.

Tokai J Exp Clin Med. 1988;13 Suppl:117-23.

PMID:
3273611
9.

Characterization of the filamentous hemagglutinin from Bordetella pertussis by gel electrophoresis.

An der Lan B, Cowell JL, Burstyn DG, Manclark CR, Chrambach A.

Mol Cell Biochem. 1986 Apr;70(1):31-55.

PMID:
2872590
10.

Antibodies to Bordetella pertussis in human colostrum and their protective activity against aerosol infection of mice.

Oda M, Cowell JL, Burstyn DG, Thaib S, Manclark CR.

Infect Immun. 1985 Feb;47(2):441-5.

11.
12.

Pertussis encephalopathy with a normal brain biopsy and elevated lymphocytosis-promoting factor antibodies.

Davis LE, Burstyn DG, Manclark CR.

Pediatr Infect Dis. 1984 Sep-Oct;3(5):448-51. No abstract available.

PMID:
6093068
13.

Immunologic response to early and routine DTP immunization in infants.

Baraff LJ, Leake RD, Burstyn DG, Payne T, Cody CL, Manclark CR, St Geme JW Jr.

Pediatrics. 1984 Jan;73(1):37-42.

PMID:
6318185
14.

Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis.

Burstyn DG, Baraff LJ, Peppler MS, Leake RD, St Geme J Jr, Manclark CR.

Infect Immun. 1983 Sep;41(3):1150-6.

15.

Separation and purification of the hemagglutinins from Bordetella pertussis.

Sato Y, Cowell JL, Sato H, Burstyn DG, Manclark CR.

Infect Immun. 1983 Jul;41(1):313-20.

Supplemental Content

Loading ...
Support Center